AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter BeatInvestors Business Daily • 10/30/24
AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer's Disease and Neuroscience PipelinePRNewsWire • 10/28/24
Curious about AbbVie (ABBV) Q3 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 10/25/24
AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric ConditionsPRNewsWire • 10/24/24
My Dividend Stock Portfolio: New September Dividend Record - 100 Holdings With 12 BuysSeeking Alpha • 10/23/24
BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)PRNewsWire • 10/18/24
U.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's DiseasePRNewsWire • 10/17/24
Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer'sBusiness Wire • 10/16/24
Allergan Aesthetics to Present New Data at 2024 American Society for Dermatologic Surgery (ASDS) to Showcase Depth Across Facial Aesthetics and Insight into Patient PerceptionPRNewsWire • 10/16/24
Dividend Aristocrat AbbVie Just Paid Investors; Here's How Much They Received24/7 Wall Street • 10/15/24